These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 5678850)
1. [The "adjuvans disease" and various problems in the pathogenesis of lupus erythematosus disseminatus]. Tarejew EM; Sura WW Dtsch Gesundheitsw; 1968 Jun; 23(23):1057-62. PubMed ID: 5678850 [No Abstract] [Full Text] [Related]
2. [Modelling autoimmune processes and certain aspects of the pathogenesis of systemic lupus erythematosus]. Tareev EM; Sura VV; Traianova TG; Komissarova IA Sov Med; 1969 Sep; 32(9):5-11. PubMed ID: 5396890 [No Abstract] [Full Text] [Related]
3. Autoantibodies: friend or foe? Sharp GC; Irvin WS Am J Med Sci; 1970 Jun; 259(6):365-72. PubMed ID: 4912273 [No Abstract] [Full Text] [Related]
4. The virus-activated suppressor cell hypothesis in experimental and human rheumatic diseases. Kapusta MA J Rheumatol; 1980; 7(3):309-15. PubMed ID: 6157023 [TBL] [Abstract][Full Text] [Related]
5. General concepts of autosensitivity in disease. Parish WE Adv Biol Skin; 1971; 11():233-66. PubMed ID: 4124139 [No Abstract] [Full Text] [Related]
7. The pathogenesis of autoimmunity in New Zealand mice. 3. Factors influencing the formation of anti-nucleic acid antibodies. Steinberg AD; Pincus T; Talal N Immunology; 1971 Apr; 20(4):523-31. PubMed ID: 5553068 [TBL] [Abstract][Full Text] [Related]
8. [Role of delayed hypersensitivity in the development of autoimmunisation]. Ryzewska A Reumatologia; 1968; 6(3):227-36. PubMed ID: 4882937 [No Abstract] [Full Text] [Related]
9. [The mechanism of action of immunomodulating preparations ( an analysis of their therapeutic effect in a model of experimental cardiomyopathy]. Groppa LG; Kobets VA; Andreev IuL Revmatologiia (Mosk); 1991; (3):30-2. PubMed ID: 1812560 [No Abstract] [Full Text] [Related]
10. Modes of action of Freund's adjuvants in experimental models of autoimmune diseases. Billiau A; Matthys P J Leukoc Biol; 2001 Dec; 70(6):849-60. PubMed ID: 11739546 [TBL] [Abstract][Full Text] [Related]
11. [Oral lesions in systemic lupus erythematosus. I. The etiopathogenic aspects of lupus erythematosus]. Bonaccorso A; Tripi TR Minerva Stomatol; 1998; 47(1-2):27-31. PubMed ID: 9578644 [TBL] [Abstract][Full Text] [Related]
12. Requirement of dying cells and environmental adjuvants for the induction of autoimmunity. Bondanza A; Zimmermann VS; Dell'Antonio G; Cin ED; Balestrieri G; Tincani A; Amoura Z; Piette JC; Sabbadini MG; Rovere-Querini P; Manfredi AA Arthritis Rheum; 2004 May; 50(5):1549-60. PubMed ID: 15146425 [TBL] [Abstract][Full Text] [Related]
13. [Cytopathic effect of lymphocytes in patients with lupus erythematosus disseminatus]. Zhuravlev GI; Shishkin VI; Panyshin AG Sov Med; 1973 Aug; 36(8):69-72. PubMed ID: 4273036 [No Abstract] [Full Text] [Related]
15. Some aspects of autoimmunity. Roitt IM Clin Sci; 1971 Aug; 41(2):1P. PubMed ID: 5564309 [No Abstract] [Full Text] [Related]
16. [Principles of immunoregulation in autoimmune syndromes]. Skotnicki AB Postepy Hig Med Dosw; 1983; 37(4):345-87. PubMed ID: 6233544 [No Abstract] [Full Text] [Related]
17. [Apoptosis in the regulation of immune processes and in the pathogenesis of autoimmune diseases]. Müzes G; Igaz P Orv Hetil; 1997 May; 138(21):1315-20. PubMed ID: 9254350 [TBL] [Abstract][Full Text] [Related]
19. [Lysosomal apparatus of the reticuloendothelial system cells and the pathogenesis of systemic lupus erythematosus]. Volkova ZI; Kaĭnova AS Vopr Revm; 1980; (3):55-8. PubMed ID: 6158792 [No Abstract] [Full Text] [Related]